Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sedation in Pediatric ICU
NCT00875550Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dexmedetomidine in sedation, sponsored by Pfizer. Started Jan 2010; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT00875550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00875550.